Rtw Investments, LP Standard Biotools Inc. Transaction History

Rtw Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $4.85 Million - $10.8 Million	-2,109,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $148,294 - $389,152	32,029 Added 1.54%	2,109,500 $9.77 Million
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $1.68 Million - $2.08 Million	146,537 Added 7.59%	2,077,471 $25.6 Million
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $8.87 Million - $15 Million	1,046,699 Added 118.37%	1,930,934 $25.7 Million
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $6.35 Million - $7.81 Million	884,235 New	884,235 $7.62 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $175M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.